Skip to content

The effect of ketamine on extubation/awakening time in children

The effect of ketamine on extubation/awakening time in children

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400083787
Enrollment
Unknown
Registered
2024-05-02
Start date
2024-05-02
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative extubation/awakening time

Interventions

Physiological saline group:Normal saline
Low concentration ketamine group (0.1mg/kg):Low concentration ketamine
Medium concentration ketamine group (0.3mg/kg):Medium concentration ketamine
High concentration ketamine group (0.5mg/kg):High concentration ketamine

Sponsors

Guangzhou Women and Children’s Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
3 Years to 6 Years

Inclusion criteria

Inclusion criteria: 1) Age between 3-6y, gender is not limited; 2) Children planning to undergo general anesthesia with laryngeal mask, ASA anesthesia grade I-II; 3) Children who choose to undergo laparoscopic hernia surgery, laparoscopic testicular fixation surgery, or laparoscopic high ligation of the sheath process; 4) The parents or legal guardians of the affected child have signed an informed consent form for medical research.

Exclusion criteria

Exclusion criteria: 1) Children with allergies to ketamine and its components; Children with severe thrombocytopenia and gastrointestinal ulcers. 2) Analgesics, sedatives, antiemetics, and antipruritic drugs were used 24 hours before surgery; 3) Children with symptoms of acute upper respiratory tract infection before surgery; 4) Children with a history of bronchial asthma; 5) Children with severe sleep apnea syndrome and arrhythmia; 6) Has a history of abnormal surgical anesthesia recovery in the past; Preoperative assessment of the presence or possibility of difficult airway conditions 7) Renal dysfunction (BUN and/or Cr>upper limit of normal value); Liver function damage (ALT and/or AST>1.5 times the upper limit of normal values); 8) Children who are deemed unsuitable for inclusion by researchers due to other circumstances.

Design outcomes

Primary

MeasureTime frame
Time to stop inhaling sevoflurane;trachea canula extubated time;

Secondary

MeasureTime frame
BIS value when stopping inhalation of sevoflurane;Body movement time;Eye opening time;Times with BIS values of 70 respectively;Time with BIS values of 80 respectively;Time with BIS values of 90 respectively;

Countries

China

Contacts

Public ContactNa Zhang

Guangzhou Women and Children's Medical Centre

na999666@163.com+86 135 6040 9867

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026